These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 453689)

  • 1. Effects of 1 alpha,25-dihydroxycholecalciferol on disuse osteoporosis in the dog: a histomorphometric study.
    Caywood DD; Wallace LJ; Olson WG; Stevens JB
    Am J Vet Res; 1979 Jan; 40(1):89-91. PubMed ID: 453689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immobilization osteoporosis and active vitamin D: effect of active vitamin D analogs on the development of immobilization osteoporosis in rats.
    Izawa Y; Makita T; Hino S; Hashimoto Y; Kushida K; Inoue T; Orimo H
    Calcif Tissue Int; 1981; 33(6):623-30. PubMed ID: 6799174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of 1,25-dihydroxycholecalciferol in renal osteopathy].
    Reutter FW; Sieber R; Olah AJ; Dambacher MA
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1880-3. PubMed ID: 531567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ipriflavone treatment on osteoporosis induced by immobilization.
    Földes I; Rapcsák M; Szöör A; Gyarmati J; Szilágyi T
    Acta Morphol Hung; 1988; 36(1-2):79-93. PubMed ID: 3149863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcitriol in disorders of bone and calcium metabolism.
    Riggs BL
    Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of 1,25-dihydroxycholecalciferol on 47calcium absorption in post-menopausal osteoporosis.
    Caniggia A; Vattimo A
    Clin Endocrinol (Oxf); 1979 Jul; 11(1):99-103. PubMed ID: 519874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of 1,25-dihydroxycholecalciferol in normal and uraemic man.
    Coburn JW; Brickman AS; Massry SG; Singer FR; Norman AW
    Proc Eur Dial Transplant Assoc; 1973; 10(0):210-6. PubMed ID: 4802387
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
    Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
    J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
    Vattimo A
    Minerva Med; 1979 Dec; 70(54):3705-7. PubMed ID: 523001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25 dihydroxycholecalciferol treatment of uraemic rats after high magnesium feeding.
    Binswanger U; Schiffl H; Huggler M; Becker C
    Proc Eur Dial Transplant Assoc; 1980; 17():563-8. PubMed ID: 6894642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microradiographic studies on the bone tissue of dogs with osteoporosis, osteodystrophia fibrosa and osteomalacia].
    Dämmrich K
    Zentralbl Veterinarmed A; 1970 May; 17(5):385-97. PubMed ID: 4987401
    [No Abstract]   [Full Text] [Related]  

  • 12. [Calcium phosphate metabolism during therapy with 1,25-dihydroxycholecalciferol [1,25 DHCC (Ro 21/5535)] in patients with advanced kidney insufficiency].
    Schulz W; Spiegel P; Gessler U; Delling G
    Verh Dtsch Ges Inn Med; 1978; (84):1297-301. PubMed ID: 741953
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of osteoporosis with 24,25 dihydroxycholecalciferol.
    Reeve J; Tellez M; Green JR; Hesp R; Elsasser U; Wootton R; Hulme P; Williams D; Kanis JA; Russell RG; Mawer EB; Meunier PJ
    Acta Endocrinol (Copenh); 1982 Dec; 101(4):636-40. PubMed ID: 6984270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-dihydroxycholecalciferol in hypoparathyroidism.
    Davies M; Taylor CM; Hill LF; Stanbury SW
    Lancet; 1977 Jan; 1(8002):55-9. PubMed ID: 63708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1.25 dihydroxycholecalciferol on calcium phosphorus and magnesium balance in preterm infants.
    Senterre J; David L; Salle B
    Ann Endocrinol (Paris); 1979; 40(2):163-4. PubMed ID: 475308
    [No Abstract]   [Full Text] [Related]  

  • 16. 1,25-dihydroxycholecalciferol and 1alpha-hydroxycholecalciferol in hypoparathyroidism.
    Russell RG; Smith R; Walton RJ; Preston C; Basson R; Henderson RG; Norman AW
    Lancet; 1974 Jul; 2(7871):14-7. PubMed ID: 4134407
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of tamoxifen citrate on canine immobilization (disuse) osteoporosis.
    Waters DJ; Caywood DD; Turner RT
    Vet Surg; 1991; 20(6):392-6. PubMed ID: 1369521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [1,25-dihydroxycholecalciferol: a hormonal form of vitamin D3].
    Schweiz Med Wochenschr; 1979 Oct; 109(38):1405-9. PubMed ID: 583366
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter: 1,25-Dihydroxycholecalciferol in hypoparathyroidism and pseudohypoparathyroidism.
    Kind HP; Prader A; DeLuca HF; Gugler E
    Lancet; 1975 May; 1(7916):1145-6. PubMed ID: 49505
    [No Abstract]   [Full Text] [Related]  

  • 20. 1,25-Dihydroxycholecalciferol: its use in the long-term management of idiopathic hypoparathyroidism in children.
    Rosen JF; Fleischman AR; Finberg L; Eisman J; DeLuca HF
    J Clin Endocrinol Metab; 1977 Sep; 45(3):457-68. PubMed ID: 903398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.